Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tetranuclear Polypyridylruthenium(II) Complexes as Selective Nucleic Acid Stains for Flow Cytometric Analysis of Monocytic and Epithelial Lung Carcinoma Large Extracellular Vesicles.

Biomolecules·2024
Same author

PCSK9 activation promotes early atherosclerosis in a vascular microphysiological system.

APL bioengineering·2023
Same author

A tetranuclear polypyridylruthenium(II) complex as a selective stain for extracellular vesicle penetration through brain microvascular endothelium.

Chemical communications (Cambridge, England)·2023
Same author

A Novel, Orally Bioavailable, Small-Molecule Inhibitor of PCSK9 With Significant Cholesterol-Lowering Properties In Vivo.

Journal of lipid research·2022
Same author

Two-Dimensional and Three-Dimensional Time-of-Flight Secondary Ion Mass Spectrometry Image Feature Extraction Using a Spatially Aware Convolutional Autoencoder.

Analytical chemistry·2022
Same author

An evaluation of the interaction of pixantrone with formaldehyde-releasing drugs in cancer cells.

Cancer chemotherapy and pharmacology·2022
Same journal

Catalytic synthesis of saturated azacycles using transborylation.

Organic & biomolecular chemistry·2026
Same journal

Pyridines with adamantane fragments and their 1,2,4-triazine analogues as anti-quorum-sensing agents, synthesis and molecular docking.

Organic & biomolecular chemistry·2026
Same journal

Synthesis of polymethylene-linked bis(cyclobutane-fused chromanones) mediated by gold photocatalysis.

Organic & biomolecular chemistry·2026
Same journal

Palladium-catalyzed chelation-assisted C-H functionalization of quinoline aldehydes to esters with mechanistic insights.

Organic & biomolecular chemistry·2026
Same journal

One-pot metal-free access to uracil-benzofuran bis-heterocycles: synthesis and DFT insights.

Organic & biomolecular chemistry·2026
Same journal

Transition-metal-free three-component synthesis of α-tertiary trifluoromethyl phosphonates from CF<sub>3</sub> diazo compounds.

Organic & biomolecular chemistry·2026
See all related articles

Related Experiment Video

Updated: Jun 8, 2026

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs
10:44

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Published on: May 15, 2019

DNA binding by pixantrone.

Najia Adnan1, Damian P Buck, Benny J Evison

  • 1School of Physical, Environmental and Mathematical Sciences University College, University of New South Wales, Australian Defence Force Academy, Northcott Drive, Campbell, ACT 2600, Australia.

Organic & Biomolecular Chemistry
|September 25, 2010
PubMed
Summary
This summary is machine-generated.

The anticancer drug pixantrone intercalates into DNA, primarily binding to CG sites from the major groove. Methylation of cytosine does not impede this binding, though some minor groove association also occurs.

More Related Videos

A Quantitative Assay to Study Protein:DNA Interactions, Discover Transcriptional Regulators of Gene Expression, and Identify Novel Anti-tumor Agents
06:43

A Quantitative Assay to Study Protein:DNA Interactions, Discover Transcriptional Regulators of Gene Expression, and Identify Novel Anti-tumor Agents

Published on: August 31, 2013

Quantitative Detection of DNA-Protein Crosslinks and Their Post-Translational Modifications
10:12

Quantitative Detection of DNA-Protein Crosslinks and Their Post-Translational Modifications

Published on: April 21, 2023

Related Experiment Videos

Last Updated: Jun 8, 2026

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs
10:44

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Published on: May 15, 2019

A Quantitative Assay to Study Protein:DNA Interactions, Discover Transcriptional Regulators of Gene Expression, and Identify Novel Anti-tumor Agents
06:43

A Quantitative Assay to Study Protein:DNA Interactions, Discover Transcriptional Regulators of Gene Expression, and Identify Novel Anti-tumor Agents

Published on: August 31, 2013

Quantitative Detection of DNA-Protein Crosslinks and Their Post-Translational Modifications
10:12

Quantitative Detection of DNA-Protein Crosslinks and Their Post-Translational Modifications

Published on: April 21, 2023

Area of Science:

  • Medicinal Chemistry
  • Structural Biology
  • Biophysics

Background:

  • Pixantrone is an anticancer drug used in treating certain leukemias.
  • Understanding drug-DNA interactions is crucial for developing effective cancer therapies.
  • DNA intercalation is a common mechanism for anticancer drugs.

Purpose of the Study:

  • To investigate the binding mode of pixantrone to DNA duplexes.
  • To determine the influence of cytosine methylation on pixantrone-DNA interactions.
  • To elucidate the structural basis of pixantrone's DNA binding.

Main Methods:

  • Nuclear Magnetic Resonance (NMR) spectroscopy was employed to study pixantrone-DNA binding.
  • Molecular modeling was used to visualize and analyze the drug-DNA complexes.
  • NOESY experiments were performed to confirm the binding mechanism and identify interaction sites.

Main Results:

  • Pixantrone binds to DNA octanucleotide duplexes via intercalation, confirmed by NMR chemical shift changes and NOE reductions.
  • The drug predominantly intercalates from the major groove at 5'-CG sites.
  • Cytosine methylation (5MeC) does not hinder major groove intercalation, and some minor groove association was observed.

Conclusions:

  • Pixantrone employs an intercalative DNA binding mechanism, primarily through the major groove.
  • The drug's interaction is not sterically hindered by 5-methylcytosine modifications.
  • Pixantrone exhibits a dual binding mode, with potential for both major and minor groove association.